Radiopharmaceuticals Show Signs of Progress in Prostate Cancer - OncLive

A. Oliver Sartor, MD

A. Oliver Sartor, MD

Radiopharmaceuticals could be part of the next wave of progress in prostate cancer treatment, pending a phase III trial evaluating efficacy with lutetium-177 PSMA-617 (Lu-PSMA-617) in patients with progressive prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC), explained A. Oliver Sartor, MD.
... to read the full story


Comments

Popular posts from this blog

I Wish I Didn't Need an Oncologist at All, But I'm Thankful for the One ...

Early symptoms of cancer in males: Common warning signs

20 Famous Men Who Have Had Prostate Cancer